WHEAT RIDGE, CO--(MARKET WIRE)--Jun 13, 2007 -- GeneThera, Inc. (OTC BB:GTHA.OB - News) announced today that it has entered into substantial negotiations with Mezey Howarth Racing Stables to develop a molecular test and vaccine for Equine infectious anemia virus (EIAV). Equine infectious anemia (EIA) is an infectious and potentially fatal horse viral disease. Currently, there is no treatment for EIAV. In 2004, there were 330 confirmed cases of EIAV.
